Search hospitals > Ohio > Canton
Aultman Health Foundation
Claim this profileCanton, Ohio 44710
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
146 reported clinical trials
7 medical researchers
Summary
Aultman Health Foundation is a medical facility located in Canton, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Aultman Health Foundation is involved with conducting 146 clinical trials across 208 conditions. There are 7 research doctors associated with this hospital, such as Sunitha Vemulapalli, Raza Khan, MD, Adarsh Vennepureddy, and Shruti Trehan.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Sunitha VemulapalliAultman Health Foundation6 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
25 reported clinical trials
76 drugs studied
Raza Khan, MDAultman Health Foundation11 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
35 drugs studied
Adarsh VennepureddyAultman Health Foundation2 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
9 reported clinical trials
30 drugs studied
Shruti TrehanAultman Health Foundation8 years of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
23 drugs studied
Clinical Trials running at Aultman Health Foundation
Lung Cancer
Breast Cancer
Breast cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Cancer
Endometrial Cancer
Uterine Cancer
Skin Cancer
Prostate Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Aultman Health Foundation?
Aultman Health Foundation is a medical facility located in Canton, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Aultman Health Foundation is involved with conducting 146 clinical trials across 208 conditions. There are 7 research doctors associated with this hospital, such as Sunitha Vemulapalli, Raza Khan, MD, Adarsh Vennepureddy, and Shruti Trehan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.